Evaluation of radiotherapy treatment plans in a randomized phase II trial comparing two schedules of twice-daily thoracic radiotherapy in limited stage small-cell lung cancer

医学 放射治疗 随机对照试验 核医学 肺癌 食管炎 阶段(地层学) 食管 临床试验 放射治疗计划 放射科 肿瘤科 外科 内科学 古生物学 生物 疾病 回流
作者
Nina Jackson Levin,Kristin Toftaker Killingberg,Tore Halvorsen,Signe Danielsen,Bjørn Henning Grønberg
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
标识
DOI:10.1016/j.ijrobp.2024.03.045
摘要

Abstract

Purpose

There is limited clinical data for recommendations on how to deliver thoracic radiotherapy (TRT) concurrently with chemotherapy in limited stage (LS) small-cell lung cancer (SCLC). We reviewed radiotherapy treatment plans in a randomized phase II trial comparing high-dose with standard-dose twice-daily TRT to assess treatment planning techniques, dose-volume data for target volumes and organs at risk (OARs), evaluate compliance with the protocol, associations with radiation-induced toxicity and whether an imbalance in treatment planning parameters might be a reason for the large survival benefit of the higher dose (median overall survival 43.6 vs. 22.6 months).

Methods and Materials

170 patients were to receive four courses of platinum/etoposide and randomized to receive twice-daily TRT of 60 Gy/40 fractions (fx) or 45 Gy/30 fx. TRT treatment plans for those who received one or more fx of TRT (n=166) were analyzed.

Results

The most common treatment planning technique was 3DCRT (67%). The 75th percentile of the reported dose-volume parameters for the OARs were within the protocol-recommended limits for both groups. Mean doses to the esophagus of 25.5 Gy (IQR: 20.2-31.3) [60 Gy/40 fx] and 24.3 Gy (IQR: 20.3-27.5) [45 Gy/30 fx] were associated with 21% and 18% ≥ grade 3 acute esophagitis, respectively. In the 60 Gy/40 fx group, a mean dose to the lungs of 16.5 Gy (IQR: 15.8-16.9), V20Gy of 29.5% (IQR: 28.8-30.4), and V5Gy of 65.6% (IQR: 61.5-68.7) led to ≥ grade 3 pneumonitis in 4% of the patients. There was no ≥ grade 3 pneumonitis in the 45 Gy group. Treatment planning techniques, the percentage change in volumes between original and re-delineated OARs, PTV volumes, relative doses, and laterality were well balanced between the randomly assigned groups.

Conclusion

Considering that the incidences of severe radiation-induced toxicities were within the range of other recent trials, the reported doses to the OARs appear to be safe. Treatment planning parameters were well balanced between the randomly assigned groups, supporting that the survival benefit of the twice-daily 60 Gy/ 40 fx TRT schedule was due to the higher dose.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
云泥完成签到,获得积分10
刚刚
刚刚
隐形曼青应助okface采纳,获得10
1秒前
zhang完成签到,获得积分10
2秒前
hopen完成签到 ,获得积分10
3秒前
丘比特应助SS采纳,获得10
5秒前
月亮moon完成签到,获得积分10
5秒前
6秒前
充电宝应助qqq采纳,获得10
9秒前
顾矜应助lihan采纳,获得10
9秒前
爆米花应助周em12_采纳,获得10
10秒前
11秒前
三物完成签到 ,获得积分10
12秒前
jolt发布了新的文献求助10
13秒前
15秒前
15秒前
16秒前
momo发布了新的文献求助10
17秒前
量子星尘发布了新的文献求助30
17秒前
18秒前
19秒前
19秒前
善学以致用应助笃定采纳,获得30
20秒前
SS发布了新的文献求助10
22秒前
22秒前
ZZZ发布了新的文献求助10
22秒前
Justtry发布了新的文献求助20
24秒前
24秒前
顾矜应助momo采纳,获得10
25秒前
25秒前
hnlgdx发布了新的文献求助20
25秒前
27秒前
重要冷之完成签到,获得积分20
27秒前
27秒前
30秒前
VV完成签到,获得积分10
30秒前
ccalvintan发布了新的文献求助10
31秒前
蛋挞发布了新的文献求助10
32秒前
小马甲应助SS采纳,获得10
35秒前
XX完成签到,获得积分10
38秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989297
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253893
捐赠科研通 3270097
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809158